SLC7A11 and neoplasm: Recent studies have discovered various ferroptosis inducers, some of which have been used for tumor therapy in clinical, for instance, sorafenib, which functions to restrain xCT activity.[42] Even so, research on strategies for therapeutic ferroptosis induction must be carefully evaluated to identify optimal compounds, doses, and schedules, as well as tumor indications in the future.